51672-4182 : Iloperidone 8 mg Oral Tablet
| NDC: | 51672-4182 |
| Labeler: | Taro Pharmaceuticals U.S.a., Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Iloperidone |
| Dosage Form: | Oral Tablet |
| Application #: | ANDA207098 |
| Rev. Date: |
Appearance:
| Markings: | T;8 |
| Shapes: |
Round |
| Colors: |
 White |
| Size (mm): | 10 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 51672-4182-4: 60 TABLET IN 1 BOTTLE (51672‑4182‑4)
Active Ingredients:
- Iloperidone
Dosage Strength:
- 8 mg
Inactive Ingredients:
- Silicon Dioxide
- Crospovidone (15 Mpa.s At 5%)
- Hypromellose, Unspecified
- Lactose Monohydrate
- Magnesium Stearate
- Microcrystalline Cellulose
- Water /
Pharmaceutical Classes:
- Atypical Antipsychotic [EPC]
Related Products:
Based on records with the same trade name.- 51672-4178 Iloperidone 1 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4179 Iloperidone 2 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4180 Iloperidone 4 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4181 Iloperidone 6 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4183 Iloperidone 10 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4184 Iloperidone 12 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.
- 51672-4213 IloperidoneIloperidone Kit by Taro Pharmaceuticals U.S.a., Inc.
- 0378-0630 Iloperidone 1 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0631 Iloperidone 2 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0632 Iloperidone 4 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0633 Iloperidone 6 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0634 Iloperidone 8 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0635 Iloperidone 10 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-0636 Iloperidone 12 mg Oral Tablet by Mylan Pharmaceuticals Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 51672-4181Next: 51672-4183 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.